CVS Health Corp (CVS)
54.65
-1.16
(-2.08%)
USD |
NYSE |
Nov 04, 16:00
54.75
+0.10
(+0.18%)
After-Hours: 20:00
CVS Health Enterprise Value: 119.04B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 119.04B |
| November 01, 2024 | 120.50B |
| October 31, 2024 | 121.32B |
| October 30, 2024 | 121.23B |
| October 29, 2024 | 121.05B |
| October 28, 2024 | 122.45B |
| October 25, 2024 | 121.36B |
| October 24, 2024 | 120.89B |
| October 23, 2024 | 121.72B |
| October 22, 2024 | 121.81B |
| October 21, 2024 | 123.47B |
| October 18, 2024 | 126.20B |
| October 17, 2024 | 130.39B |
| October 16, 2024 | 132.09B |
| October 15, 2024 | 132.06B |
| October 14, 2024 | 135.16B |
| October 11, 2024 | 134.11B |
| October 10, 2024 | 134.39B |
| October 09, 2024 | 133.28B |
| October 08, 2024 | 133.19B |
| October 07, 2024 | 132.38B |
| October 04, 2024 | 131.55B |
| October 03, 2024 | 129.45B |
| October 02, 2024 | 128.59B |
| October 01, 2024 | 127.71B |
| Date | Value |
|---|---|
| September 30, 2024 | 129.39B |
| September 27, 2024 | 127.51B |
| September 26, 2024 | 124.53B |
| September 25, 2024 | 124.06B |
| September 24, 2024 | 123.36B |
| September 23, 2024 | 122.71B |
| September 20, 2024 | 122.64B |
| September 19, 2024 | 123.76B |
| September 18, 2024 | 123.78B |
| September 17, 2024 | 123.04B |
| September 16, 2024 | 123.72B |
| September 13, 2024 | 123.23B |
| September 12, 2024 | 122.66B |
| September 11, 2024 | 120.88B |
| September 10, 2024 | 121.92B |
| September 09, 2024 | 121.33B |
| September 06, 2024 | 122.94B |
| September 05, 2024 | 123.34B |
| September 04, 2024 | 124.89B |
| September 03, 2024 | 122.48B |
| August 30, 2024 | 122.30B |
| August 29, 2024 | 121.96B |
| August 28, 2024 | 122.30B |
| August 27, 2024 | 122.58B |
| August 26, 2024 | 124.14B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
118.56B
Minimum
May 28 2024
189.42B
Maximum
Feb 08 2022
149.36B
Average
147.73B
Median
Enterprise Value Benchmarks
| Humana Inc | 19.70B |
| Amgen Inc | 221.77B |
| Walgreens Boots Alliance Inc | 16.25B |
| AirSculpt Technologies Inc | 446.15M |
| SeaStar Medical Holding Corp | 13.76M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.77B |
| Revenue (Quarterly) | 91.23B |
| Total Expenses (Quarterly) | 88.19B |
| EPS Diluted (Quarterly) | 1.41 |
| Gross Profit Margin (Quarterly) | 14.67% |
| Profit Margin (Quarterly) | 1.94% |
| Earnings Yield | 10.28% |
| Operating Earnings Yield | 17.75% |
| Normalized Earnings Yield | 10.30 |